PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn study shows 2-sided immune cell could be harnessed to shrink tumors

Penn study shows 2-sided immune cell could be harnessed to shrink tumors
2010-10-29
(Press-News.org) PHILADELPHIA - A recently identified immune cell that directs other cells to fight infection plays a critical role in regulating the immune system in both health and disease. Researchers from the University of Pennsylvania School of Medicine have discovered how a stimulatory molecule and a protein found on the membrane of another immune cell make T helper 17 cells multi-taskers of sorts. Th17 cells protect the body against infection and cancer, but are also culprits in some autoimmune diseases and out-of-control, cancerous cell growth.

This new understanding that Th17 cells manage to play both sides of the fence suggests that targeting or inhibiting the involved protein pathways might be a new way to treat cancer, chronic infection, and some autoimmune diseases. Previous studies have linked excessive amounts of Th17 cells in the body to such autoimmune diseases as multiple sclerosis, psoriasis, rheumatoid arthritis, and Crohn's disease.

First author and postdoctoral fellow Chrystal Paulos PhD; senior author Carl June, MD, professor of Pathology and Laboratory Medicine, and colleagues have found that a protein called inducible costimulator (ICOS) is necessary for the growth and function of human Th17 cells, while CD28, a transmembrane protein on CD4 cells, stops the ICOS signal. What's more, human Th17 stimulated with ICOS shrank human tumors implanted in a mouse model faster than those stimulated with CD28. The findings appear in this week's Science Translational Medicine. June is also the Program Director of Translational Research for the Abramson Family Cancer Research Institute at Penn.

These findings were surprising to the researchers given that CD28 has historically been used by investigators to study and expand human Th17 cells. The new data on Th17 cells raises the possibility that the full inflammatory potential of human Th17 cells had not been fully reflected by previous lab studies.

To move this knowledge closer to the clinic, the team also demonstrated that Th17 cells cannot only be expanded to large numbers, but could also be maintained by stimulating them with ICOS proteins. Th17 polarizing cytokines have previously been shown to support Th17 cells from naïve CD4 cells but this is the first demonstration that the ICOS costimulatory molecule used to expand the Th17 cells is important.

Tilting the balance between spurring and suppressing the growth of Th17 cells may be a key to tailoring immunotherapy, a form of cancer treatment. Adoptive transfer of tumor-specific cells expanded with ICOS and polarized to a Th17 cell type might further improve treatment.

These basic findings on Th17 cells in both peripheral and cord blood cells has broad implications, providing the basis of a new human cancer treatment protocol. T-cell-based therapies that incorporate the ICOS signal are being planned at Penn to treat patients with leukemia.



INFORMATION:

This work was supported by National Cancer Institute.

Other Penn co-authors are Carmine Carpenito, Gabriela Plesa, Megan M. Suhoski, Angel Varela-Rohena, Tatiana N. Golovina, Richard G. Carroll, and James L. Riley.

Editor's Note

A patent for the expansion of Th17 cells using ICOS has been filed based on work reported in published article.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $3.6 billion enterprise.

Penn's School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools, and is consistently among the nation's top recipients of funding from the National Institutes of Health, with $367.2 million awarded in the 2008 fiscal year.

Penn Medicine's patient care facilities include:

The Hospital of the University of Pennsylvania – the nation's first teaching hospital, recognized as one of the nation's top 10 hospitals by U.S. News & World Report. Penn Presbyterian Medical Center – named one of the top 100 hospitals for cardiovascular care by Thomson Reuters for six years. Pennsylvania Hospital – the nation's first hospital, founded in 1751, nationally recognized for excellence in orthopaedics, obstetrics & gynecology, and psychiatry & behavioral health.

Additional patient care facilities and services include Penn Medicine at Rittenhouse, a Philadelphia campus offering inpatient rehabilitation and outpatient care in many specialties; as well as a primary care provider network; a faculty practice plan; home care and hospice services; and several multispecialty outpatient facilities across the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2009, Penn Medicine provided $733.5 million to benefit our community.


[Attachments] See images for this press release:
Penn study shows 2-sided immune cell could be harnessed to shrink tumors

ELSE PRESS RELEASES FROM THIS DATE:

The unhealthy ego: What can neuroscience tell us about our 'self'?

2010-10-29
With Election Day right around the corner, political egos are on full display. One might even think that possessing a "big ego" is a prerequisite for success in politics, or in any position of leadership. High achievers–CEO's, top athletes, rock stars, prominent surgeons, or scientists–often seem to be well endowed in ego. But when does a "healthy ego" cross the line into unhealthy territory? Where is the line between confident, positive self-image and grandiose self-importance, which might signal a personality disorder or other psychiatric illness? More fundamentally, ...

Scientists investigate evolution of new polio virus

2010-10-29
The virus, called enterovirus 71, is closely related to poliovirus, and was first detected in California in the 1960s. Since then the virus has spread across Asia, affecting mostly children and some adults. Serious cases of the disease can include neurological disorders such as meningitis, paralysis and encephalitis. As a result of a global health campaign, polioviruses have almost been eradicated in many areas of the world. Enterovirus 71, however, has caused major outbreaks of hand, foot, and mouth disease and it is still unclear why such a high number of cases occur ...

Paradise lost -- and found

Paradise lost -- and found
2010-10-29
Ancient gardens are the stuff of legend, from the Garden of Eden to the Hanging Gardens of Babylon. Now researchers at Tel Aviv University, in collaboration with Heidelberg University in Germany, have uncovered an ancient royal garden at the site of Ramat Rachel near Jerusalem, and are leading the first full-scale excavation of this type of archaeological site anywhere in the pre-Hellenistic Levant. According to Prof. Oded Lipschits and graduate student Boaz Gross of Tel Aviv University's Department of Archaeology, this dig is an unparalleled look into the structure ...

Study identifies flaws in Medicare prescription drug program

2010-10-29
Millions of Medicare recipients have been forcibly reassigned to different prescription drug plans because Part D reimbursements to insurance companies covering low-income patients are lower than the actual costs incurred, according to a study released online today by Health Affairs. The report describes how a system designed to encourage competition and to subsidize care for low-income Medicare patients instead has led companies to raise their premiums in an effort to price themselves out of the low-income segment of the Part D market. "These insufficient payments create ...

U of M researchers identify possible key to treating, understanding post-traumatic stress disorder

2010-10-29
MINNEAPOLIS / ST. PAUL Minn. (October 28, 2010) – University of Minnesota Medical School and Minneapolis Veterans Affair Medical Center researchers have discovered a correlation between increased circuit activity in the right side of the brain and the debilitating, involuntary flashbacks triggered by post traumatic stress disorder (PTSD). The ability to objectively diagnose PTSD through concrete evidence of neural activity, its impact and its manifestation is the first step towards effectively helping those afflicted with this severe anxiety disorder. PTSD often stems ...

Found: First complete remains of early sauropod dinosaur

Found: First complete remains of early sauropod dinosaur
2010-10-29
Boulder, CO, USA - Scientists have discovered in China the first complete skeleton of a pivotal ancestor of Earth's largest land animals – the sauropod dinosaurs. The new species, tentatively dubbed Yizhousaurus sunae, lived on the flood plains around Lufeng in the Yunnan Province of South China about 200 million years ago. The species helps explain how the iconic four-footed, long-necked sauropod dinosaurs evolved. Unlike the 120-foot-long, 100-ton sauropod giants that came later, Yizhousaurus was about 30 feet in length, but it shows all of the hallmarks of later sauropods: ...

December 2010 Lithosphere highlights

2010-10-29
Boulder, CO, USA - The December 2010 Lithosphere analyzes tectonic histories across the Llano Uplift, Texas; activity along the ~85-mile-long Kern Canyon fault, southern Sierra Nevada; deformed mantle materials in the Twin Sisters ultramafic body of Washington State; a giant granitic intrusion called the Sahwave Intrusive Suite near Reno, Nevada; the Socorro Magma Body, New Mexico; gravity anomalies on and offshore of the Antarctic continent; and the shallow upper mantle stratification of the "Lehmann" and "X" discontinuities. Highlights are provided below. View abstracts ...

NC State develops more precise genetic 'off switches'

2010-10-29
Researchers at North Carolina State University have found a way to "cage" genetic off switches in such a way that they can be activated when exposed to UV light. Their technology gives scientists a more precise way to control and study gene function in localized areas of developing organisms. The off switches, called morpholino oligonucleotides, are like short snippets of DNA that, when introduced into cells, bind to target RNA molecules, effectively turning off specific genes. Morpholinos have been used as genetic switches in many animal models, including the zebrafish ...

Tighter ethics rules have reduced industrial relationship of NIH scientists

2010-10-29
The 2005 ethics rules that govern relationships between researchers within the National Institutes of Health (NIH) and pharmaceutical, biotechnology and other industrial companies have significantly reduced the prevalence of such collaborations without affecting standard measures of research productivity, according to a study in the November issue of Academic Medicine. However, this report from the Mongan Institute for Health Policy at Massachusetts General Hospital (MGH) also finds that NIH scientists and administrators believe the new rules are too restrictive. "Our ...

Tracking high school graduation, dropout rates

2010-10-29
High school graduation and dropout rates have long been used as a key indicator of the effectiveness of a school system, but how best to calculate these rates is controversial for both educators and policymakers. HIGH SCHOOL DROPOUT, GRADUATION, AND COMPLETION RATES: BETTER DATA, BETTER MEASURES, BETTER DECISIONS, a new report from the National Research Council and the National Academy of Education, offers guidance to the federal government, states, and schools on measuring dropout rates and collecting data to help them achieve better outcomes for students. Among ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Penn study shows 2-sided immune cell could be harnessed to shrink tumors